Researchers develop algorithm to find possible misdiagnosis

February 15, 2021

It does not happen often. But on rare occasions, physicians make mistakes and may make a wrong diagnosis. Patients may have many diseases all at once, where it can be difficult to distinguish the symptoms of one illness from the other, or there may be a lack of symptoms.

Errors in diagnosis may lead to incorrect treatment or a lack of treatment. Therefore, everyone in the healthcare system tries to minimise errors as much as possible.

Now, researchers at the University of Copenhagen have developed an algorithm that can help with just that.

'Our new algorithm can find the patients who have such an unusual disease trajectory that they may indeed not suffer from the disease they were diagnosed with. It can hopefully end up being a support tool for physicians', says Isabella Friis Jørgensen, Postdoc at the Novo Nordisk Foundation Center for Protein Research.

The algorithm revealed possible lung cancer

The researchers have developed the algorithm based on disease trajectories for 284,000 patients with chronic obstructive pulmonary disease (COPD), from 1994 to 2015. Based on these data, they came up with approximately 69,000 typical disease trajectories.

'In the National Patient Registry, we have been able to map what you could call typical disease trajectory. And if a patient shows up with a very unusual disease trajectory, then it might be that the patient is simply suffering from a different disease. Our tool can help to detect this', explains Søren Brunak, Professor at the Novo Nordisk Foundation Center for Protein Research.

For example, the researchers found a small group of 2,185 COPD patients who died very shortly after being diagnosed with COPD. According to the researchers, it was a sign that something else might have been wrong, maybe something even more serious.

'When we studied the laboratory values from these patients more closely, we saw that they deviated from normal values for COPD patients. Instead, the values resembled something that is seen in lung cancer patients. Only 10 per cent of these patients were diagnosed with lung cancer, but we are reasonably convinced that most, if not all of these patients actually had lung cancer', explains Søren Brunak.

Data that will provide an immediate benefit

Although the algorithm was validated through data from COPD patients, it may be used for many other diseases. The principle is the same: the algorithm uses registry data to map the typical disease trajectories and can detect if some patients' disease trajectory stand out so much that something may be wrong.

'Naturally, our most important goal is for the patients to get their money's worth with respect to their health care. And we believe that in the future, this algorithm may end up becoming a support tool for physicians. Once the algorithm has mapped the typical disease trjaectories, it only takes 10 seconds to match a single patient against everyone else', says Søren Brunak.

He emphasises that the algorithm must be further validated and tested in clinical trials before it can be implemented in Danish hospitals. But he hopes it is something that can be started soon.

'In Denmark, we often praise our good health registries because they contain valuable data for researchers. We use them in our research because it may benefit other people in the future in the form of better treatment. But this is actually an example of how your own health data can benefit yourself right away', says Søren Brunak.
-end-


University of Copenhagen - The Faculty of Health and Medical Sciences

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.